Overview
Marc Gautier is a Hematologist in Lebanon, New Hampshire. Dr. Gautier is highly rated in 49 conditions, according to our data. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia, Thrombocytopenia, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1 Medical Center Dr Ste 4, Lebanon, NH 03756
173 Middle St, Lancaster, NH 03584
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Mary Hitchcock Memorial Hospital
Frederick Lansigan is a Hematologist in Lebanon, New Hampshire. Dr. Lansigan is highly rated in 32 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Cutaneous T-Cell Lymphoma (CTCL), Bone Marrow Aspiration, and Bone Marrow Transplant.
Office
Kathryn Hourdequin is a Hematologist in Lebanon, New Hampshire. Dr. Hourdequin is highly rated in 14 conditions, according to our data. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Cholangiocarcinoma (Bile Duct Cancer).
Mary Hitchcock Memorial Hospital
Sergey Devitskiy is a Hematologist in Lebanon, New Hampshire. Dr. Devitskiy is highly rated in 24 conditions, according to our data. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Clear Cell Sarcoma, and WT1-Related Wilms Tumor Syndromes.
Frequently Asked Questions about Dr. Marc Gautier
How do I make an appointment with Dr. Marc Gautier?
You can book an appointment with Dr. Marc Gautier by calling their office at 802-473-4100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Marc Gautier a top-rated expert for Chronic Lymphocytic Leukemia (CLL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Marc Gautier is classified as an Distinguished expert for Chronic Lymphocytic Leukemia (CLL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Marc Gautier specialize in?
While Dr. Marc Gautier is a Hematology, they have specific expertise in Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia, and Thrombocytopenia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Marc Gautier participate in research or clinical trials?
Yes. Dr. Marc Gautier has published 2 articles and abstracts on conditions like Chronic Lymphocytic Leukemia (CLL). You can view a list of Dr. Marc Gautier's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Marc Gautier accept my insurance?
Dr. Marc Gautier accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 802-473-4100 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic B-Cell Leukemia (CBCL)Dr. Gautier isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Gautier isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Clear Cell SarcomaDr. Gautier isDistinguished. Learn about Clear Cell Sarcoma.
- Large-Cell Immunoblastic LymphomaDr. Gautier isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Gautier isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Gautier isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Gautier isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Gautier isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- AngiosarcomaDr. Gautier isAdvanced. Learn about Angiosarcoma.
- Experienced
- Acute Eosinophilic PneumoniaDr. Gautier isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Lymphoblastic Leukemia (ALL)Dr. Gautier isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Mountain SicknessDr. Gautier isExperienced. Learn about Acute Mountain Sickness.
- Adult T-Cell LeukemiaDr. Gautier isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Gautier isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Gautier isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.